» Articles » PMID: 21486905

Mechanisms Controlling Th17 Cytokine Expression and Host Defense

Overview
Journal J Leukoc Biol
Date 2011 Apr 14
PMID 21486905
Citations 58
Authors
Affiliations
Soon will be listed here.
Abstract

Th17 cells contribute to mucosal immunity by stimulating epithelial cells to induce antimicrobial peptides, granulopoiesis, neutrophil recruitment, and tissue repair. Recent studies have identified important roles for commensal microbiota and Ahr ligands in stabilizing Th17 gene expression in vivo, linking environmental cues to CD4 T cell polarization. Epigenetic changes that occur during the transition from naïve to effector Th17 cells increase the accessibility of il17a, il17f, and il22 loci to transcription factors. In addition, Th17 cells maintain the potential for expressing T-bet, Foxp3, or GATA-binding protein-3, explaining their plastic nature under various cytokine microenvironments. Although CD4 T cells are major sources of IL-17 and IL-22, innate cell populations, including γδ T cells, NK cells, and lymphoid tissue-inducer cells, are early sources of these cytokines during IL-23-driven responses. Epithelial cells and fibroblasts are important cellular targets for IL-17 in vivo; however, recent data suggest that macrophages and B cells are also stimulated directly by IL-17. Thus, Th17 cells interact with multiple populations to facilitate protection against intracellular and extracellular pathogens.

Citing Articles

Immunogenicity and vaccine efficacy of -derived extracellular vesicles as a novel vaccine candidate.

Park S, Kim Y, Lee H, Han J, Seo B, Park G Virulence. 2025; 16(1):2453818.

PMID: 39831520 PMC: 11749362. DOI: 10.1080/21505594.2025.2453818.


Transcriptome Analysis of Human Dermal Cells Infected with Candida auris Identified Unique Pathogenesis/Defensive Mechanisms Particularly Ferroptosis.

Fayed B, Shakartalla S, Sabbah H, Dalle H, Tannira M, Senok A Mycopathologia. 2024; 189(4):65.

PMID: 38990436 DOI: 10.1007/s11046-024-00868-9.


Characterising plasmacytoid and myeloid AXL+ SIGLEC-6+ dendritic cell functions and their interactions with HIV.

Warner van Dijk F, Tong O, ONeil T, Bertram K, Hu K, Baharlou H PLoS Pathog. 2024; 20(6):e1012351.

PMID: 38924030 PMC: 11233022. DOI: 10.1371/journal.ppat.1012351.


Epithelial responses to CFTR modulators are improved by inflammatory cytokines and impaired by antiinflammatory drugs.

Rehman T, Pezzulo A, Thurman A, Zemans R, Welsh M JCI Insight. 2024; 9(14.

PMID: 38888974 PMC: 11383177. DOI: 10.1172/jci.insight.181836.


Entire expressed peripheral blood transcriptome in pediatric severe malarial anemia.

Anyona S, Cheng Q, Wasena S, Osata S, Guo Y, Raballah E Nat Commun. 2024; 15(1):5037.

PMID: 38866743 PMC: 11169501. DOI: 10.1038/s41467-024-48259-4.


References
1.
Fossiez F, Djossou O, Chomarat P, Flores-Romo L, Maat C, Pin J . T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J Exp Med. 1996; 183(6):2593-603. PMC: 2192621. DOI: 10.1084/jem.183.6.2593. View

2.
Hughes T, Becknell B, Freud A, McClory S, Briercheck E, Yu J . Interleukin-1beta selectively expands and sustains interleukin-22+ immature human natural killer cells in secondary lymphoid tissue. Immunity. 2010; 32(6):803-14. PMC: 3742307. DOI: 10.1016/j.immuni.2010.06.007. View

3.
Witowski J, Pawlaczyk K, Breborowicz A, Scheuren A, Wisniewska J, Polubinska A . IL-17 stimulates intraperitoneal neutrophil infiltration through the release of GRO alpha chemokine from mesothelial cells. J Immunol. 2000; 165(10):5814-21. DOI: 10.4049/jimmunol.165.10.5814. View

4.
Raffatellu M, Santos R, Verhoeven D, George M, Wilson R, Winter S . Simian immunodeficiency virus-induced mucosal interleukin-17 deficiency promotes Salmonella dissemination from the gut. Nat Med. 2008; 14(4):421-8. PMC: 2901863. DOI: 10.1038/nm1743. View

5.
Martin B, Hirota K, Cua D, Stockinger B, Veldhoen M . Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals. Immunity. 2009; 31(2):321-30. DOI: 10.1016/j.immuni.2009.06.020. View